StockData

Mplx Lp vs Plains All American Pipeline LP

MPLX and PAA side by side, both in industrials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MPLX and PAA compare

Mplx Lp is the larger company, worth 3.4 times as much as Plains All American Pipeline LP ($58.0B against $17.2B).

Plains All American Pipeline LP grew revenue faster over the last twelve months (22.2% versus 8.7% for Mplx Lp).

Both pay dividends: Mplx Lp yields 5.6% and Plains All American Pipeline LP 6.8%.

Plains All American Pipeline LP scores higher on the StockData Score (12 against 5 for Mplx Lp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMPLXPAA
Size and price
Market cap$58.0B$17.2B
Share price$57.25$24.44
Change, 1 year9.1%48.0%
Change, 5 years92.9%143%
Beta (5Y)0.420.50
Employees5,7623,900
StockData Score
Total score512 (better)
Valuation score03 (better)
Growth score12 (better)
Performance score02 (better)
Health score12 (better)
Dividend score33
Valuation
P/S4.4×0.3× (better)
EV/EBITDA14.1×9.9× (better)
P/FCF17.4×7.6× (better)
FCF yield5.7%13.2% (better)
Fair value$55.40$39.05
Margin of safety−3.3%37.4% (better)
Growth
Revenue growth (TTM)8.7%22.2% (better)
Revenue growth, 5Y average11.4%13.7% (better)
Net income growth (TTM)–138%
Profitability
Gross margin–7.6%
Operating margin44.4% (better)3.0%
Net margin–4.8%
FCF margin25.2% (better)4.1%
Financial health
Net debt / EBITDA4.193.41 (better)
Interest coverage4.8× (better)2.7×
Current ratio0.891.09 (better)
Altman Z-score1.96–
Piotroski F-score–5
Dividends and buybacks
Dividend yield5.6%6.8% (better)
Buyback yield0.52%–
Shareholder yield6.2%6.8% (better)
Ownership
Held by institutions19.4%41.0%
Held by insiders0.17%35.1%
Insider net buying, 12 months−$199K−$51.5K (better)
Superinvestors holding2–
Short interest, % of float0.68%–

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.